STOCK TITAN

Revolution Medicines (NASDAQ: RVMD) trust plans 3,000-share Rule 144 sale

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Revolution Medicines, Inc. (symbol RVMD) received a notice that The Jonathan Goldsmith Revocable Trust, with Mark A. Goldsmith signing as trustee, has filed to sell shares of the company under Rule 144. The trust plans to sell 3,000 shares of common stock that were originally acquired as Founders Shares on 11/25/2014. The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with a stated aggregate market value of about $635,205.00 tied to 214,336,418 shares referenced in the form.

The filing also reports that during the past three months, 10,020 shares of Revolution Medicines common stock were sold on 06/16/2026 for total proceeds of approximately $1,564,310.38. The notice is signed and dated, indicating an intention to rely on Rule 144’s resale provisions for these securities.

Positive

  • None.

Negative

  • None.
Shares to be sold 3,000 shares of common stock Planned Rule 144 sale by The Jonathan Goldsmith Revocable Trust
Aggregate market value reference $635,205.00 Value figure associated with the securities line on NASDAQ
Shares referenced 214,336,418 shares Share count referenced alongside the $635,205.00 value
Past 3 months shares sold 10,020 shares Common stock sold on 06/16/2026 over the past three months
Proceeds from past 3 months sales $1,564,310.38 Total consideration for 10,020 shares sold on 06/16/2026
Acquisition date of Founders Shares 11/25/2014 Original acquisition date for the 3,000 Founders Shares
Planned sale date reference 08/21/2026 Date associated with the securities information line for NASDAQ
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Founders Shares financial
"Common | 11/25/2014 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Form 144 regulatory
"144: Filer Information ... 144: Issuer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Revocable Trust financial
"Name of Person ... THE JONATHAN GOLDSMITH REVOCABLE TRUST"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

FAQ

What does the Form 144 filing disclose for Revolution Medicines (RVMD)?

It discloses that The Jonathan Goldsmith Revocable Trust intends to sell 3,000 shares of Revolution Medicines common stock under Rule 144, and that 10,020 shares were sold in the past three months for about $1,564,310.38.

How many RVMD shares does the Jonathan Goldsmith Revocable Trust plan to sell?

The Jonathan Goldsmith Revocable Trust plans to sell 3,000 shares of Revolution Medicines common stock. These shares are identified as Founders Shares originally acquired on 11/25/2014.

What recent sales of RVMD stock are reported in this Form 144?

The filing reports that on 06/16/2026, 10,020 shares of Revolution Medicines common stock were sold, with total proceeds of approximately $1,564,310.38 over the past three months.

Who is executing the planned Rule 144 sale for RVMD shares?

The planned sale of 3,000 RVMD shares under Rule 144 is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with the shares listed on the NASDAQ market according to the filing.

What type of RVMD shares are being sold under this Form 144?

The filing identifies the securities as common stock of Revolution Medicines, described as Founders Shares acquired on 11/25/2014, with 3,000 shares covered by the current Rule 144 sale notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature